19. November 2009 22:48
High irradiances of low-level laser therapy (LLLT) should not be used over melanomas. Researchers writing in the open access journal BMC Cancer studied the pain relieving, anti-inflammatory 'cold laser', finding that it caused increased tumour growth in a mouse model of skin cancer.
[More]
19. November 2009 08:41
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
[More]
19. November 2009 03:46
Over 300 million patients use non-steroidal anti-inflammatory drugs (NSAIDs) in the world to treat pain, arthritis, fever and other diseases. Nearly 30% of the users suffer from gastric lesions and bleeding.
[More]
7960f209-1487-488b-96eb-89e0354e0e77|0|.0
Posted in: Medical Science News | Pharmaceutical News
Tags: Anti-Inflammatory, Apoptosis, Arthritis, Cancer, Cell, Colorectal Cancer, Esophageal Cancer, Gastroenterology, Hepatology, Indomethacin, Liver Cancer, Ulcer
19. November 2009 02:36
Every two years, 2,000 senior Group Health patients check in with the Adult Changes in Thought (ACT) study. The joint project between Group Health Research Institute and the University of Washington (UW) focuses on finding ways to delay or prevent dementia, including Alzheimer's disease, and declines in memory and thinking.
[More]
b8645f7a-360b-4e84-8d26-80c779fd4e42|0|.0
Posted in: Medical Condition News
Tags: Alzheimer's Disease, Anti-Inflammatory, Atrial Fibrillation, Blood Pressure, Blood Vessel, Brain, Cholesterol, Dementia, Diabetes, Exercise, Kidney Disease, Nervous System, Seniors, Sleep, Statin
19. November 2009 00:49
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
[More]
259b6317-e2c9-41a9-839b-c824711a233a|0|.0
Posted in: Drug Trial News | Pharmaceutical News
Tags: Anti-Inflammatory, Arthritis, Biomarker, Biotechnology, Cardiovascular Disease, Hospital, Macrophage, Rheumatoid Arthritis, Stent, Transplant, Ultrasound, Virus
18. November 2009 04:01
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
[More]
18. November 2009 03:04
Aeolus Pharmaceuticals, Inc. announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts.
[More]
9cc6e5d3-b581-4e45-8159-6d64d2a5c2da|0|.0
Posted in: Medical Science News | Medical Condition News | Pharmaceutical News
Tags: Angiogenesis, Anti-Inflammatory, Antioxidant, Cancer, Cell, Chemotherapy, Epilepsy, Fibrosis, Hypoxia, Lung Cancer, Macrophage, Manganese, Non-Small Cell Lung Cancer, Oxidative Stress, Paclitaxel, Radiation Exposure, Radiation Therapy, Radiotherapy, Small Cell Lung Cancer, Stress, Toxicology, VEGF, Weight Loss
18. November 2009 00:07
someone at home who has H1N1 (swine) flu, it is important for you to prevent other people in the house from getting sick, according to Gary Kalkut, MD, MPH, Senior Vice-President, Chief Medical Officer of Montefiore Medical Center.
[More]
17. November 2009 04:58
New antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) and other pesky bacteria. Andrei Osterman and collaborators have used comparisons of bacterial genomes to identify new targets for antibiotics and produced first-generation chemical inhibitors of a class of bacterial enzymes, called NadDs (nicotinate mononucleotide adenylyltransferases).
[More]
a7bd67ba-2c84-4ccf-8674-066aea4a1ec5|0|.0
Posted in: Device / Technology News | Medical Science News
Tags: Antibiotic, Anti-Inflammatory, Blood Vessel, Brain, Cancer, Cell, Diabetes, Hydrogen Peroxide, Immunosuppression, Insulin, Insulin Resistance, Juvenile Diabetes, Metastasis, Neurological Disease, Obesity, Parkinson's Disease, Pathology, Staphylococcus aureus, Stem Cell
17. November 2009 04:28
UC Irvine pharmacology researchers have discovered a way to boost levels of a natural body fat that helps decrease inflammation, pointing to possible new treatments for allergies, illnesses and injuries related to the immune system.
[More]
17. November 2009 04:10
Results of the SLIM Study ("Slo-Niacin® and Atorvastatin Treatment of Lipoproteins and Inflammatory Markers in Combined Hyperlipidemia") were recently published in the Journal of Clinical Lipidology.
[More]
fb3789c9-4d82-442c-a5f1-72d2e21cad7b|0|.0
Posted in: Medical Condition News | Miscellaneous News
Tags: Anti-Inflammatory, Antioxidant, Atherosclerosis, Atorvastatin, Brain, Calcium, Cholesterol, Hyperlipidemia, Lipoprotein, Myopathy, Pfizer, Statin, Stroke, Triglyceride
16. November 2009 06:42
Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.
[More]
fd796e5e-208d-417d-9b00-0ff666bb589e|0|.0
Posted in: Business / Finance | Pharmaceutical News
Tags: Allergy, Antibody, Anti-Inflammatory, Antiviral Drug, Arthritis, Avian Influenza, Cancer, Cell, Cervical Cancer, Diabetes, DNA, Exercise, Gene Expression, Gene Therapy, H1N1, H5N1, Hepatitis C, Influenza, Investment, Malaria, New Drug Application, Pandemic, Prostate Cancer, Rheumatoid Arthritis, Swine Flu, Vaccine, Virus
16. November 2009 05:24
The Committee for Orphan Medical Products (COMP) of the European Medicines Agency (EMEA) has issued a recommendation granting orphan drug status to Proteo's drug candidate Elafin for the treatment of esophagus carcinoma. The orphan drug status will become effective upon ratification of this recommendation by the European Commission.
[More]
16. November 2009 04:53
"Now that we know how the body defends itself against the Chlamydia bacteria, we can develop a vaccine that optimises that defence. We have a basic understanding of how the vaccine could work, but some work remains to be done. We believe that it will take a few years before the vaccine becomes a reality," says researcher Ellen Marks, the author of the thesis.
[More]
16. November 2009 01:11
Researchers at Emory University and the Georgia Institute of Technology have developed microscopic polymer beads that can deliver an antioxidant enzyme made naturally by the body into the heart.
[More]